RIA
STAB

Realta Investment Advisors’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Realta Investment Advisors’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5
Closed – – 1851
2019
Q2 		$0 Buy
+5
New +$8 ﹤0.01% 1839

Other funds holding STAB

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Realta Investment Advisors's STAB Position: Q3 2019 in Review

Realta Investment Advisors sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q3 2019, closing a stake of 5 shares.

Realta Investment Advisors first reported a position in STAB in Q2 2019 and held it in 1 quarter. The position peaked at $0 in Q2 2019. 17 funds tracked by Wall St. Rank hold STAB as of Q3 2019.

  • Realta Investment Advisors reported no remaining Statera Biopharma, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Realta Investment Advisors sold 5 Statera Biopharma, Inc. Common Stock shares in Q3 2019.
  • Realta Investment Advisors first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Realta Investment Advisors's Statera Biopharma, Inc. Common Stock position peaked at $0 in Q2 2019.
  • 17 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q3 2019.

Based on Realta Investment Advisors's 13F filing for Q3 2019, filed 18 Oct 2019.